Chemotherapy for lung cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy7

Lung Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Lymph Nodes Mediastinum Bronchi

Organisms4

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL

Diseases59

Lung Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Small Cell Lung Diseases Adenocarcinoma Breast Neoplasms Small Cell Lung Carcinoma Neoplasms Carcinoma, Squamous Cell Neoplasm Metastasis Ovarian Neoplasms Neoplasm Recurrence, Local Carcinoma, Large Cell Stomach Neoplasms Lung Injury Neoplasm Invasiveness Disease Progression Colonic Neoplasms Carcinoma Prostatic Neoplasms Colorectal Neoplasms Pancreatic Neoplasms Genetic Predisposition to Disease Bone Neoplasms Neutropenia Acute Lung Injury Liver Neoplasms Brain Neoplasms Urinary Bladder Neoplasms Testicular Neoplasms Nausea Head and Neck Neoplasms Neoplasms, Second Primary Uterine Cervical Neoplasms Vomiting Rectal Neoplasms Carcinoma, Bronchogenic Occupational Diseases Mesothelioma Adenocarcinoma, Bronchiolo-Alveolar Lymphatic Metastasis Esophageal Neoplasms Cell Transformation, Neoplastic Lymphoma, Non-Hodgkin Neoplasms, Radiation-Induced Lung Diseases, Interstitial Peritoneal Neoplasms Hodgkin Disease Neovascularization, Pathologic Leukopenia Recurrence Neoplasms, Multiple Primary Neoplasms, Glandular and Epithelial Neoplasms, Germ Cell and Embryonal Lymphoma Thrombocytopenia Gastrointestinal Neoplasms Pleural Neoplasms Carcinoma, Lewis Lung

Chemicals and Drugs62

Antineoplastic Agents Cisplatin Cyclophosphamide Doxorubicin Etoposide Paclitaxel Tumor Markers, Biological Carboplatin Taxoids Deoxycytidine Vinblastine Antineoplastic Agents, Phytogenic Neoplasm Proteins Antimetabolites, Antineoplastic Quinazolines Receptor, Epidermal Growth Factor Methotrexate RNA, Messenger Organoplatinum Compounds Bleomycin Radon Ifosfamide DNA, Neoplasm Antibodies, Monoclonal Camptothecin Receptor, erbB-2 Tumor Suppressor Protein p53 Anthracyclines Antibiotics, Antineoplastic Cancer Vaccines Protein Kinase Inhibitors Antibodies, Monoclonal, Humanized Receptors, Estrogen RNA, Small Interfering Antineoplastic Agents, Alkylating Antigens, Neoplasm Mitomycin Platinum Compounds Vindesine Tamoxifen Asbestos Cytarabine Radiopharmaceuticals Platinum Tumor Suppressor Proteins Granulocyte Colony-Stimulating Factor Carcinogens Tegafur Antineoplastic Agents, Hormonal Air Pollutants, Radioactive Receptors, Progesterone MicroRNAs DNA-Binding Proteins Lomustine Proto-Oncogene Proteins Anticarcinogenic Agents Dacarbazine Bridged Compounds Mitoxantrone Carcinoembryonic Antigen RNA, Neoplasm Guanine

Analytical, Diagnostic and Therapeutic Techniques and Equipment80

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Combined Modality Therapy Neoplasm Staging Treatment Outcome Prognosis Survival Analysis Survival Rate Disease-Free Survival Early Detection of Cancer Drug Administration Schedule Follow-Up Studies Prospective Studies Neoadjuvant Therapy Pneumonectomy Risk Factors Kaplan-Meier Estimate Lung Transplantation Clinical Trials as Topic Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Tomography, X-Ray Computed Radiotherapy Risk Immunohistochemistry Retrospective Studies Multivariate Analysis Gene Expression Profiling Induction Chemotherapy Radiotherapy, Adjuvant Risk Assessment Neoplasm Transplantation Palliative Care Radiotherapy Dosage Tumor Burden Sensitivity and Specificity Predictive Value of Tests Blotting, Western Case-Control Studies Odds Ratio Drug Screening Assays, Antitumor Salvage Therapy Cohort Studies Incidence Transplantation, Heterologous Registries Infusions, Intravenous Molecular Targeted Therapy Positron-Emission Tomography Chemotherapy, Cancer, Regional Perfusion Chemoradiotherapy Oligonucleotide Array Sequence Analysis Clinical Trials, Phase III as Topic Reproducibility of Results Bronchoscopy Polymerase Chain Reaction SEER Program Lung Volume Measurements Feasibility Studies Proportional Hazards Models Immunoenzyme Techniques Flow Cytometry Transplantation, Autologous Questionnaires Logistic Models Randomized Controlled Trials as Topic Cranial Irradiation Confidence Intervals Immunotherapy Transfection Pilot Projects Clinical Trials, Phase II as Topic Fatal Outcome Models, Biological Drug Therapy Radiography, Thoracic Lymph Node Excision Drug Delivery Systems Mastectomy Gene Knockdown Techniques

Psychiatry and Psychology1

Phenomena and Processes32

Drug Resistance, Neoplasm Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Time Factors Mutation Apoptosis Risk Genetic Predisposition to Disease Cell Proliferation Sensitivity and Specificity Cell Survival Odds Ratio DNA Methylation Genotype Polymorphism, Genetic Signal Transduction Down-Regulation Genes, p53 Cell Division Drug Synergism Cell Movement Cell Cycle Promoter Regions, Genetic Gene Expression Genes, Tumor Suppressor Up-Regulation Genes, ras Cell Growth Processes RNA Interference Transfection Gene Silencing Base Sequence

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science8

Survival Rate Incidence Registries SEER Program Questionnaires Base Sequence Fatal Outcome Molecular Sequence Data

Named Groups1

Health Care36

Treatment Outcome Survival Analysis Survival Rate Disease-Free Survival Follow-Up Studies Prospective Studies Risk Factors Kaplan-Meier Estimate Clinical Trials as Topic Risk Retrospective Studies Multivariate Analysis Risk Assessment Age Factors Palliative Care Sensitivity and Specificity Predictive Value of Tests Case-Control Studies Odds Ratio Cohort Studies Incidence Registries Occupational Exposure Clinical Trials, Phase III as Topic Reproducibility of Results National Cancer Institute (U.S.)SEER Program Feasibility Studies Proportional Hazards Models Questionnaires Logistic Models Randomized Controlled Trials as Topic Confidence Intervals Pilot Projects Clinical Trials, Phase II as Topic Fatal Outcome

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Antineoplastic Combined Chemotherapy Protocols Lung Neoplasms Carcinoma, Non-Small-Cell Lung Lung Chemotherapy, Adjuvant Antineoplastic Agents Cisplatin Carcinoma, Small Cell Combined Modality Therapy Neoplasm Staging Treatment Outcome Prognosis Lung Diseases Adenocarcinoma Survival Analysis Survival Rate Breast Neoplasms Small Cell Lung Carcinoma Disease-Free Survival Cyclophosphamide Cell Line, Tumor Neoplasms Carcinoma, Squamous Cell Neoplasm Metastasis Doxorubicin Etoposide Smoking Drug Resistance, Neoplasm Early Detection of Cancer Paclitaxel Tumor Markers, Biological Ovarian Neoplasms Drug Administration Schedule Gene Expression Regulation, Neoplastic Carboplatin Follow-Up Studies Neoplasm Recurrence, Local Taxoids Mice, Nude Deoxycytidine Vinblastine Prospective Studies Carcinoma, Large Cell Neoadjuvant Therapy Stomach Neoplasms Lung Injury Pneumonectomy Antineoplastic Agents, Phytogenic Neoplasm Invasiveness Risk Factors Disease Progression Colonic Neoplasms Kaplan-Meier Estimate Neoplasm Proteins Carcinoma Prostatic Neoplasms Antimetabolites, Antineoplastic Quinazolines Colorectal Neoplasms Receptor, Epidermal Growth Factor Lung Transplantation Methotrexate Dose-Response Relationship, Drug Clinical Trials as Topic Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Time Factors Mutation Pancreatic Neoplasms Apoptosis Tomography, X-Ray Computed Radiotherapy Tumor Cells, Cultured Risk RNA, Messenger Organoplatinum Compounds Bleomycin Immunohistochemistry Genetic Predisposition to Disease Radon Retrospective Studies Multivariate Analysis Gene Expression Profiling Cell Proliferation Induction Chemotherapy Ifosfamide Radiotherapy, Adjuvant DNA, Neoplasm Bone Neoplasms Risk Assessment Age Factors Antibodies, Monoclonal Neoplasm Transplantation Palliative Care Radiotherapy Dosage Camptothecin Tumor Burden Neutropenia Sensitivity and Specificity Acute Lung Injury

No FAQ available that match "chemotherapy for lung cancer"